141 related articles for article (PubMed ID: 1679759)
1. Effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines.
Takeda Y; Escribano MJ
J Cancer Res Clin Oncol; 1991; 117(5):416-20. PubMed ID: 1679759
[TBL] [Abstract][Full Text] [Related]
2. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer.
Robertson JF; Watson SA; Hardcastle JD
Int J Cancer; 1995 Sep; 63(1):69-75. PubMed ID: 7558455
[TBL] [Abstract][Full Text] [Related]
3. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
[TBL] [Abstract][Full Text] [Related]
4. A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines.
Nio Y; Ohmori H; Minari Y; Hirahara N; Sasaki S; Takamura M; Tamura K
Anticancer Drugs; 1997 Aug; 8(7):686-95. PubMed ID: 9311445
[TBL] [Abstract][Full Text] [Related]
5. Expression of fetoacinar pancreatic (FAP) protein in the pancreatic human tumor cell line BxPC-3.
Mazo A; Fujii Y; Shimotake J; Escribano MJ
Pancreas; 1991 Jan; 6(1):37-45. PubMed ID: 1994378
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts.
Celinski SA; Fisher WE; Amaya F; Wu YQ; Yao Q; Youker KA; Li M
J Surg Res; 2003 Nov; 115(1):41-7. PubMed ID: 14572771
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
Lu YY; Jing DD; Xu M; Wu K; Wang XP
World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
[TBL] [Abstract][Full Text] [Related]
8. sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells.
Delesque N; Buscail L; Estève JP; Saint-Laurent N; Müller C; Weckbecker G; Bruns C; Vaysse N; Susini C
Cancer Res; 1997 Mar; 57(5):956-62. PubMed ID: 9041201
[TBL] [Abstract][Full Text] [Related]
9. Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.
Shimizu Y; Demetris AJ; Gollin SM; Storto PD; Bedford HM; Altarac S; Iwatsuki S; Herberman RB; Whiteside TL
Int J Cancer; 1992 Sep; 52(2):252-60. PubMed ID: 1355757
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
Kuramoto M; Yamashita J; Ogawa M
Cancer; 1995 Mar; 75(6):1263-72. PubMed ID: 7882277
[TBL] [Abstract][Full Text] [Related]
11. Characterization of six cell lines established from human pancreatic adenocarcinomas.
Kato M; Shimada Y; Tanaka H; Hosotani R; Ohshio G; Ishizaki K; Imamura M
Cancer; 1999 Feb; 85(4):832-40. PubMed ID: 10091760
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer.
Rochaix P; Delesque N; Estève JP; Saint-Laurent N; Voight JJ; Vaysse N; Susini C; Buscail L
Hum Gene Ther; 1999 Apr; 10(6):995-1008. PubMed ID: 10223733
[TBL] [Abstract][Full Text] [Related]
13. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse.
Fisher WE; Muscarella P; Boros LG; Schirmer WJ
Surgery; 1998 Mar; 123(3):315-20. PubMed ID: 9526524
[TBL] [Abstract][Full Text] [Related]
14. [Establishment and characterization of human pancreatic adenocarcinoma cell line SOJ producing carcinoembryonic antigen and carbohydrate antigen 19-9].
Fujii Y; Sekiguchi M; Shiroko Y; Shimizu H; Sugawara I; Hasumi K; Eriguchi M; Ikeuchi T; Uchida H
Hum Cell; 1990 Mar; 3(1):31-6. PubMed ID: 2083222
[TBL] [Abstract][Full Text] [Related]
15. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Weckbecker G; Raulf F; Bodmer D; Bruns C
Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1.
Fralix KD; Ahmed MM; Mattingly C; Swiderski C; McGrath PC; Venkatasubbarao K; Kamada N; Mohiuddin M; Strodel WE; Freeman JW
Cancer; 2000 May; 88(9):2010-21. PubMed ID: 10813711
[TBL] [Abstract][Full Text] [Related]
17. Novel therapeutic approach for cancer using four cardiovascular hormones.
Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
[TBL] [Abstract][Full Text] [Related]
18. Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2.
Liehr RM; Melnykovych G; Solomon TE
Gastroenterology; 1990 Jun; 98(6):1666-74. PubMed ID: 2186957
[TBL] [Abstract][Full Text] [Related]
19. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth of MKN45 human gastric-carcinoma xenografts in nude mice by treatment with bombesin/gastrin-releasing-peptide antagonist (RC-3095) and somatostatin analogue RC-160.
Pinski J; Halmos G; Yano T; Szepeshazi K; Qin Y; Ertl T; Schally AV
Int J Cancer; 1994 May; 57(4):574-80. PubMed ID: 7910153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
